000 | 01972 a2200529 4500 | ||
---|---|---|---|
005 | 20250516230700.0 | ||
264 | 0 | _c20150401 | |
008 | 201504s 0 0 eng d | ||
022 | _a1873-2518 | ||
024 | 7 |
_a10.1016/j.vaccine.2014.08.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan de Sandt, Carolien E | |
245 | 0 | 0 |
_aNovel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine. _h[electronic resource] |
260 |
_bVaccine _cSep 2014 |
||
300 |
_a5614-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Viral _xblood |
650 | 0 | 4 | _aAntibody Formation |
650 | 0 | 4 | _aAntigen Presentation |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCross Reactions _ximmunology |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 |
_aDiterpenes _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfluenza A Virus, H1N1 Subtype |
650 | 0 | 4 | _aInfluenza A Virus, H3N2 Subtype |
650 | 0 | 4 | _aInfluenza B virus |
650 | 0 | 4 |
_aInfluenza Vaccines _ximmunology |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
650 | 0 | 4 |
_aOrthomyxoviridae Infections _xprevention & control |
650 | 0 | 4 |
_aVaccines, Inactivated _ximmunology |
700 | 1 | _aKreijtz, Joost H C M | |
700 | 1 | _aGeelhoed-Mieras, Martina M | |
700 | 1 | _aVogelzang-van Trierum, Stella E | |
700 | 1 | _aNieuwkoop, Nella J | |
700 | 1 | _avan de Vijver, David A M C | |
700 | 1 | _aFouchier, Ron A M | |
700 | 1 | _aOsterhaus, Albert D M E | |
700 | 1 | _aMorein, Bror | |
700 | 1 | _aRimmelzwaan, Guus F | |
773 | 0 |
_tVaccine _gvol. 32 _gno. 43 _gp. 5614-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2014.08.003 _zAvailable from publisher's website |
999 |
_c24114895 _d24114895 |